Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie) during the COVID-19 pandemic: Much more than just telemedicine

Diabetes Res Clin Pract. 2020 Nov:169:108396. doi: 10.1016/j.diabres.2020.108396. Epub 2020 Sep 3.

Abstract

We describe our experience in the remote management of women with gestational diabetes mellitus during the COVID-19 pandemic. We used a mobile phone application with artificial intelligence that automatically classifies and analyses the data (ketonuria, diet transgressions, and blood glucose values), making adjustment recommendations regarding the diet or insulin treatment.

Keywords: Artificial intelligence; Gestational diabetes mellitus; Mobile phone application; Telemedicine; eHealth.

MeSH terms

  • Artificial Intelligence
  • Blood Glucose / analysis
  • Blood Glucose Self-Monitoring / methods
  • COVID-19 / complications*
  • COVID-19 / virology
  • Diabetes, Gestational / blood
  • Diabetes, Gestational / epidemiology
  • Diabetes, Gestational / therapy*
  • Diabetes, Gestational / virology
  • Disease Management
  • Female
  • Humans
  • Pregnancy
  • SARS-CoV-2 / isolation & purification*
  • Smartphone / statistics & numerical data*
  • Spain / epidemiology
  • Telemedicine / methods*

Substances

  • Blood Glucose